Castle Creek Pharmaceuticals Announces First Patient Enrolled in DELIVERS Study of Diacerein 1 Ointment for Epidermolysis Bullosa Simplex

Press/Media: Press / Media

PeriodJun 5 2017

Media coverage

1

Media coverage

  • TitleCastle Creek Pharmaceuticals Announces First Patient Enrolled in DELIVERS Study of Diacerein 1 Ointment for Epidermolysis Bullosa Simplex
    Media name/outletBioPortfolio
    CountryUnited Kingdom
    Date6/5/17
    PersonsJohn C Browning